Investigation of the effects of statin therapy on serum vitamin E status in patients with dyslipidemia

Ghayour-Mobarhan, M. and Sahebkar, A. and Starkey, B. J. and Livingstone, C. and Wang, T. and Lamb, D. J. and Ferns, G. A. A. (2008) Investigation of the effects of statin therapy on serum vitamin E status in patients with dyslipidemia. Pakistan Journal of Nutrition, 7 (4). pp. 561-565.

[img] Text
Investigation of the effects of statin therapy on serum vitamin E status in patients with dyslipidemia.pdf

Download (37kB)


There are limited data on the effects of statins on serum vitamin E status in dyslipidaemic patients, and no comparisons between statins have been published previously. We have investigated the effect of Atorvastatin and Simvastatin on serum vitamin E status in dyslipidaemic patients. A total of 20 dyslipidaemic patients (14 males, 6 females, mean age 49.15±3.28 years), previously not treated with a lipid lowering agent, were recruited into the study. These patients were randomized to treatment group and received either: Simvastatin 10mg/day (n = 11) or Atorvastatin 10mg/day (n = 9) for 4 months. The control group comprised 14 patients from the same clinic, who were given lifestyle advice, but whose drug treatment remained unchanged for the duration of the study. Serum concentrations of vitamin E, high sensitivity C-reactive protein (hs-CRP) and fasted lipid profiles pre- and post-treatment were measured in all subjects. There were the expected significant reductions in serum lipids in the patients treated with either statin (P<0.001). Overall statin treatment was also associated with a significant reduction in serum vitamin E (21, P<0.001) and hs-CRP (45, P<0.05). There was no significant change in these parameters in the control patients. The serum vitamin E/total cholesterol ratio was not significantly altered in patients receiving Atorvastatin, or Simvastatin despite the significant reduction in serum vitamin E. No change in vitamin E status was observed in the controls. © Asian Network for Scientific Information, 2008.

Item Type: Article
Additional Information: Cited By :1 Export Date: 16 February 2020 Correspondence Address: Ferns, G.A.A.; Center for Clinical Science and Measurement, School of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH, United Kingdom
Uncontrolled Keywords: Atorvastatin Cholesterol High sensitivity C-reactive protein (hs-CRP) Simvastatin Vitamin E alpha tocopherol C reactive protein glucose high density lipoprotein cholesterol hydroxymethylglutaryl coenzyme A reductase inhibitor lipid low density lipoprotein cholesterol triacylglycerol adult article cholesterol blood level clinical article clinical trial combination chemotherapy controlled clinical trial controlled study drug efficacy dyslipidemia female glucose blood level human lifestyle modification lipid blood level male monotherapy protein blood level randomized controlled trial triacylglycerol blood level vitamin blood level
Subjects: WD Nutrition Disease and metabolic diseases
QU Biochemistry
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib3 lib3
Date Deposited: 29 Apr 2020 08:33
Last Modified: 29 Apr 2020 08:33

Actions (login required)

View Item View Item